Author:
Degener Stephan,Schmalz Oliver,Tosch Marco,Gödde Daniel,von Rundstedt Friedrich-Carl,Piroth Marc D.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Zentrum für Krebsregisterdaten (2021) Krebs in Deutschalnd für 2017/2018. Robert-Koch-Institut, Berlin
2. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF) S3-Leitlinie Prostatakarzinom2021 06.07.2022; Langversion 6.2. http://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/. Zugegriffen: 03.04.2023
3. Coll PP, Korc-Grodzicki B, Ristau BT, Shahrokni A, Koshy A, Filippova OT et al (2020) Cancer prevention and screening for older adults: Part 2. Interventions to prevent and screen for breast, prostate, cervical, ovarian, and endometrial cancer. J Am Geriatr Soc 68(11):2684–2691
4. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424
5. Vickers AJ, Sjoberg DD, Ulmert D, Vertosick E, Roobol MJ, Thompson I et al (2014) Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen. BMC Med 12:26